Considerations for determining safety of probiotics: A USP perspective

Updated on

Several stakeholders, including the United States Pharmacopeia (USP), have an interest in developing best practice guidelines for assessing the quality and safety of probiotics. This review provides a summary guide to global regulatory guidelines and outlines the essential parameters of a comprehensive safety assessment for a probiotic product.

REFERENCE:

Roe AL, Boyte ME, Elkins CA, Goldman VS, Heimbach J, Madden E, Oketch-Rabah H, Sanders ME, Sirois J, Smith A. Considerations for determining safety of probiotics: A USP perspective. Regul Toxicol Pharmacol 2022; 136:105266. doi: 10.1016/j.yrtph.2022.105266.

Related Content